Correspondence 0001005286-24-000156 from LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
LIFECORE BIOMEDICAL, INC. \DE\
Date: Oct. 18, 2024 · CIK: 0001005286 · Accession: 0001005286-24-000156
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282583
Letter
Document
Lifecore Biomedical, Inc.
3515 Lyman Boulevard
Chaska, MN 55318
October 18, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Eranga Dias
Re: Lifecore Biomedical, Inc.
Registration Statement on Form S-1
File No. 333-282583
To the addressee set forth above:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-282583) (the “Registration Statement”) of Lifecore Biomedical, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m. Eastern Time on October 22, 2024 or as soon as practicable thereafter, or at such other time thereafter as our counsel, Latham & Watkins LLP, may request by telephone. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Darren Guttenberg at (714) 755-8050 or, in his absence, J. Ross McAloon at (714) 755-8051.
Thank you for your assistance in this matter.
Sincerely,
LIFECORE BIOMEDICAL, INC.
Show Raw Text
CORRESP 1 filename1.htm Document Lifecore Biomedical, Inc. 3515 Lyman Boulevard Chaska, MN 55318 October 18, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Eranga Dias Re: Lifecore Biomedical, Inc. Registration Statement on Form S-1 File No. 333-282583 To the addressee set forth above: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-282583) (the “Registration Statement”) of Lifecore Biomedical, Inc. We respectfully request that the Registration Statement become effective as of 4:00 p.m. Eastern Time on October 22, 2024 or as soon as practicable thereafter, or at such other time thereafter as our counsel, Latham & Watkins LLP, may request by telephone. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Darren Guttenberg at (714) 755-8050 or, in his absence, J. Ross McAloon at (714) 755-8051. Thank you for your assistance in this matter. Sincerely, LIFECORE BIOMEDICAL, INC. By: /s/ Ryan D. Lake Ryan D. Lake Chief Financial Officer cc: Paul Josephs, Lifecore Biomedical, Inc. Darren Guttenberg, Latham & Watkins LLP J. Ross McAloon, Latham & Watkins LLP